Stocks · Health care · Pharmaceutical Preparations

Nuvation Bio Inc.

NUVB Clue Score46
United States Fiscal year ends December CIK 0001811063 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
David Hung
President and CEO
—
—
—
59,281,054
$420.44M
+1.7%
Junyuan Jerry Wang
CEO, Anheart Therapeutics Ltd.
—
—
—
3,866,228
$27.42M
−1.4%
Robert Mashal
Director
—
—
—
225,000
$1.60M
+125.0%
Colleen Sjogren
Chief Commercial Officer
—
—
—
81,000
$574.48K
+161.3%
Moses Makunje
See Remarks
—
—
—
68,137
$483.25K
+292.1%
Philippe Sauvage
Chief Financial Officer
—
—
—
54,131
$383.92K
+692.4%
Kerry Wentworth
Chief Regulatory Officer
—
—
—
53,000
$375.90K
+1,667%
Stacy Markel
Chief People Officer
—
—
—
32,591
$231.15K
+44.3%
David C. Hanley
Chief Technical Operations
—
—
—
24,000
$170.22K
0.0%
Dongfang Liu
Chief Medical Officer
—
—
—
18,000
$127.66K
0.0%
Gary Hattersley
Chief Scientific Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.